VanEck Associates
STJ

VanEck Associates’s St Jude Medical STJ Stock Holding History

VanEck Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-611,800
Closed -$33.6M – 899
2016
Q1 		$33.6M Buy
611,800
+610,149
+36,956% +$33.2M 0.23% 96
2015
Q4 		$102K Buy
1,651
+531
+47% +$33.5K ﹤0.01% 618
2015
Q3 		$71K Buy
1,120
+165
+17% +$11.8K ﹤0.01% 652
2015
Q2 		$70K Buy
955
+126
+15% +$9.1K ﹤0.01% 676
2015
Q1 		$54K Buy
829
+397
+92% +$26.4K ﹤0.01% 690
2014
Q4 		$28K Buy
+432
New +$27.8K ﹤0.01% 703

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VanEck Associates's STJ Position: Q2 2016 in Review

VanEck Associates sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 611,800 shares — an estimated $33.6M sold.

VanEck Associates first reported a position in STJ in Q4 2014 and held it in 6 quarters. The position peaked at $33.6M in Q1 2016. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • VanEck Associates reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • VanEck Associates sold 611,800 St Jude Medical shares in Q2 2016, an estimated $33.6M.
  • VanEck Associates first reported a position in St Jude Medical in Q4 2014 and held it in 6 quarters.
  • VanEck Associates's St Jude Medical position peaked at $33.6M in Q1 2016.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on VanEck Associates's 13F filing for Q2 2016, filed 12 Aug 2016.